• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. Alimera Sciences' ILUVIEN® Receives Marketing Authorization In The Netherlands For The Treatment Of Chronic Diabetic Macular Edema

    Alimera Sciences' ILUVIEN® Receives Marketing Authorization In The Netherlands For The Treatment Of Chronic Diabetic Macular Edema

  2. SciFluor Life Sciences Awarded U.S. Patent for Integrin αvβ3 Inhibitors Designed for the Topical Treatment of Retinal Disease

    SciFluor Life Sciences Awarded U.S. Patent for Integrin αvβ3 Inhibitors Designed for the Topical Treatment of Retinal Disease

  3. IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions

    IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions

  4. iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Update

    iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Update

  5. Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing

    Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.